BBBruna Baccega

Bruna Baccega

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bruna Baccega has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    First Insights into the Biological Activity and Molecular Docking of Citral (3,7-Dimethyl-2, 6-Octadienal) Against Trichomonas vaginalis

    by Alexia Brauner de Mello, Juliana Montelli Fenalti, Bruna Baccega, Yan Wahast Islabão, Filipe Obelar Martins, Paloma Taborda Birmann, Angela Maria Casaril, Tallyson Nogueira Barbosa, Angela Sena-Lopes, Francieli Liz Monteiro, et al.

    The increasing resistance of Trichomonas vaginalis to the only approved chemical family of drugs for treatment, the 5-nitroimidazoles, has prompted the exploration of new therapeutic agents against this prevalent non-viral sexually transmitted infection. Natural products have emerged as a significant source of novel treatments for trichomoniasis. The aim of this study was to evaluate the anti-T. vaginalis activity of citral (3,7-dimethyl-2,6-octadienal), the main constituent of the essential oil of Cymbopogon species, commonly known as lemongrass. Our findings indicate that citral exhibits a minimum inhibitory concentration (MIC) of 100 μM, effectively inhibiting the growth of T. vaginalis trophozoites within 12 h of exposure, and a 50% inhibitory concentration (IC50) of approximately 40 μM after 24 h. Furthermore, the evaluation of nitric oxide (NO) levels suggests that citral possesses antioxidant properties. Molecular docking studies reveal a weak interaction with three parasite proteins: thioredoxin reductase (TvTrxR), purine nucleoside phosphorylase (TvPNP), and methionine gamma lyase (TvMGL). The present study highlights the potential of citral as a candidate for the development of no-nitroimidazole drugs, offering new avenues for trichomoniasis treatment and underscoring the importance of further investigation into citral’s mechanism of action.


    • 1 January 2021
      • Vol. 11  (1) , 32-43
    Open Access

    In vitro and in vivo activity of the essential oil and nanoemulsion of Cymbopogon flexuosus against Trichomonas gallinae

    by Bruna Baccega, Yan Wahast Islabao, Alexia Brauner de Mello, Filipe Obelar Martins, Carolina Caetano dos Santos, Aline Ferreira Ourique, Samanta da Silva Gundel, Marcia Raquel Pegoraro de Macedo, Elvia Elena Silveira Vianna, Nara Amelia da Rosa Farias, et al.

    Objective: This study was done to evaluate the in vitro and in vivo effects of the essential oil (OE-CL) and nanoemulsion (N-CL) of Cymbopogon flexuosus against Trichomonas gallinae. Materials and Methods: In vitro assays were done with 10(6) parasites and OE-CL and N-CL in the concentrations: 110, 220, 330, 440, 550, 660, 770 and 880 mu g/ml and four controls: CN (culture medium and trophozoites), MTZ (trophozoites plus 800 mu g/ml of metronidazole), TW (trophozoites plus vehicles used for solubilization of derivatives (0.01% Tween) and NB (blank nanoemulsion 880 mu g/ml). The in vivo assay was done in 35 quails (Coturnix coturnix) infected experimentally 4x10(4) mg/kg, were divided in seven groups (n=5): A (control-healthy), B (control infected), C (control TW 0.01%), D (NB 0.88 mg/kg), E (drug MTZ 25 mg/kg, F (OE-CL at 0.55 mg/kg) and G (N-CL at 0.44 mg/kg), during 7 consecutive days. Results: The in vitro test showed that the OE-CL (550 mu g/ml) and N-CL (440 mu g/ml) concentrations reduced the trophozoites viability in 100%. In the in vivo test, the treatment with OE-CL was efficient on the 4th treatment day and the N-CL after the 3th day, and the MTZ in the therapeutic concentration was efficient on the 7th day. Conclusion: It can be observed in this study that the lemon grass has natural potential antitrichomonal activity against T. gallinae in vitro and in vivo.